1. 633 Dual-targeting of 4–1BB and OX40 with an ADAPTIR™ bispecific antibody enhances anti-tumor responses to solid tumor. (10th December 2020) Authors: Nelson, Michelle; Miller, Robert; Blahnik-Fagan, Gabriele; Loh, Lauren; Citters, Danielle Van; Misher, Lynda; Sprague, Megan; Dasovich, Maria; Barber, Irene; Maggiora, Kathy; Gruswitz, Franz; Woodruff, Brian; Huntington, Kelsey; Guinn, Aelish; Aguilar, Megan; Daugherty, Mollie; Haglin, Elizabeth;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 633 Dual-targeting of 4–1BB and OX40 with an ADAPTIR™ bispecific antibody enhances anti-tumor responses to solid tumor. (9th November 2020) Authors: Nelson, Michelle; Miller, Robert; Blahnik-Fagan, Gabriele; Loh, Lauren; Citters, Danielle Van; Misher, Lynda; Sprague, Megan; Dasovich, Maria; Barber, Irene; Maggiora, Kathy; Gruswitz, Franz; Woodruff, Brian; Huntington, Kelsey; Guinn, Aelish; Aguilar, Megan; Daugherty, Mollie; Haglin, Elizabeth;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗